Headquartered in Morgantown, West Virginia, Protea Biosciences Group (OTCQB:PRGB) is a commercial stage molecular information company. The company's proprietary technology platform, molecular information services and molecular data and informatics products afford a more rapid and comprehensive analysis of biological samples as compared to traditional instruments and methods. Largely targeted to medical researchers (although also having applications in other areas including agriculture, biodefense and forensics) and offering certain benefits over legacy instruments, the company's technology affords the potential to facilitate significant advancements in fields such as pharmaceutical research and development and biomarker discovery.
At the forefront of Protea's proprietary offerings is their LAESI® (laser ablation electrospray ionization) technology platform for use with mass spectrometry. Mass spectrometry is used
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|